These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18386012)

  • 21. Detection of hepatocellular carcinoma: comparison of dynamic MR imaging with dynamic double arterial phase helical CT.
    Noguchi Y; Murakami T; Kim T; Hori M; Osuga K; Kawata S; Kumano S; Okada A; Sugiura T; Nakamura H
    AJR Am J Roentgenol; 2003 Feb; 180(2):455-60. PubMed ID: 12540451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance of multidetector row computed tomography, superparamagnetic iron oxide-enhanced magnetic resonance imaging, and dual-contrast magnetic resonance imaging in predicting the appropriateness of a transplant recipient based on milan criteria: correlation with histopathological findings.
    Lee DH; Kim SH; Lee JM; Park HS; Lee JY; Yi NJ; Suh KS; Jang JJ; Han JK; Choi BI
    Invest Radiol; 2009 Jun; 44(6):311-21. PubMed ID: 19462486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT.
    Lee JM; Kim IH; Kwak HS; Youk JH; Han YM; Kim CS
    Korean J Radiol; 2003; 4(1):1-8. PubMed ID: 12679628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidetector row CT and MR imaging in diagnosing hepatocellular carcinoma.
    Murakami T; Hori M; Kim T; Kawata S; Abe H; Nakamura H
    Intervirology; 2004; 47(3-5):209-26. PubMed ID: 15383731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of hypovascular hepatic nodules with positive uptake of gadoxetic acid in patients with cirrhosis.
    Sano K; Ichikawa T; Motosugi U; Ichikawa S; Morisaka H; Enomoto N; Matsuda M; Fujii H
    Eur Radiol; 2017 Feb; 27(2):518-525. PubMed ID: 27255397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of hemodynamic imaging findings of hypervascular hepatocellular carcinoma: comparison between dynamic contrast-enhanced magnetic resonance imaging using radial volumetric imaging breath-hold examination with k-space-weighted image contrast reconstruction and dynamic computed tomography during hepatic arteriography.
    Kurozumi M; Fujinaga Y; Kitou Y; Yamada A; Ohya A; Adachi Y; Tsukahara Y; Nickel MD; Maruyama K; Uehara T; Miyagawa SI; Kadoya M
    Jpn J Radiol; 2018 Apr; 36(4):295-302. PubMed ID: 29327116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
    Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of hypervascular hepatocellular carcinoma by dynamic magnetic resonance imaging with double-echo chemical shift in-phase and opposed-phase gradient echo technique: comparison with dynamic helical computed tomography imaging with double arterial phase.
    Noguchi Y; Murakami T; Kim T; Hori M; Osuga K; Kawata S; Okada A; Sugiura T; Tomoda K; Narumi Y; Nakamura H
    J Comput Assist Tomogr; 2002; 26(6):981-7. PubMed ID: 12488747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypovascular nodules in patients with chronic liver disease: risk factors for development of hypervascular hepatocellular carcinoma.
    Hyodo T; Murakami T; Imai Y; Okada M; Hori M; Kagawa Y; Kogita S; Kumano S; Kudo M; Mochizuki T
    Radiology; 2013 Feb; 266(2):480-90. PubMed ID: 23362095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of hypervascular hepatocellular carcinoma: Comparison of multi-detector CT with digital subtraction angiography and Lipiodol CT.
    Zheng XH; Guan YS; Zhou XP; Huang J; Sun L; Li X; Liu Y
    World J Gastroenterol; 2005 Jan; 11(2):200-3. PubMed ID: 15633215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of arterial hypervascularity of hepatocellular carcinoma: comparison of contrast-enhanced US and gadoxetate disodium-enhanced MR imaging.
    Sugimoto K; Moriyasu F; Shiraishi J; Saito K; Taira J; Saguchi T; Imai Y
    Eur Radiol; 2012 Jun; 22(6):1205-13. PubMed ID: 22270142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ferucarbotran-enhanced 3.0-T magnetic resonance imaging using parallel imaging technique compared with triple-phase multidetector row computed tomography for the preoperative detection of hepatocellular carcinoma.
    Kim SJ; Kim SH; Lee J; Chang S; Kim YS; Kim SH; Jeon YH; Choi D
    J Comput Assist Tomogr; 2008; 32(3):379-85. PubMed ID: 18520541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria.
    Leoni S; Piscaglia F; Golfieri R; Camaggi V; Vidili G; Pini P; Bolondi L
    Am J Gastroenterol; 2010 Mar; 105(3):599-609. PubMed ID: 19935786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
    Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
    Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Kim YK; Ko SW; Hwang SB; Kim CS; Yu HC
    Eur Radiol; 2006 Jun; 16(6):1337-45. PubMed ID: 16453115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection and characterization of hepatocellular carcinoma in rats with liver cirrhosis: diagnostic value of combined use of MR positive and negative contrast agents.
    Guo DM; Qiu TS; Bian J; Liu SF; Wang CZ
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):65-70. PubMed ID: 19208518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fast 3D dynamic MR imaging of the liver with MR SmartPrep: comparison with helical CT in detecting hypervascular hepatocellular carcinoma.
    Tomemori T; Yamakado K; Nakatsuka A; Sakuma H; Matsumura K; Takeda K
    Clin Imaging; 2001; 25(5):355-61. PubMed ID: 11682296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypervascular focus in the nonhypervascular nodule ("nodule-in-nodule") on dynamic computed tomography: imaging evidence of aggressive progression in hepatocellular carcinoma.
    Yu JS; Chung JJ; Kim JH; Kim KW
    J Comput Assist Tomogr; 2009; 33(1):131-5. PubMed ID: 19188800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.